{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:19:21Z","timestamp":1784956761743,"version":"3.55.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jbc.2022.102860","type":"journal-article","created":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T10:44:47Z","timestamp":1672483487000},"page":"102860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Exploration of aminoacyl-tRNA synthetases from eukaryotic parasites for drug development"],"prefix":"10.1016","volume":"299","author":[{"given":"Jasmita","family":"Gill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2022.102860_bib1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3389\/fimmu.2019.00549","article-title":"Infectious disease threats in the twenty-first century: strengthening the global response","volume":"10","author":"Bloom","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2022.102860_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpddr.2013.10.001","article-title":"Aminoacyl-tRNA synthetases as drug targets in eukaryotic parasites","volume":"4","author":"Pham","year":"2013","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.jbc.2022.102860_bib3","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.12688\/f1000research.7924.1","article-title":"Recent advances in understanding apicomplexan parasites","volume":"5","author":"Seeber","year":"2016","journal-title":"F1000Research"},{"key":"10.1016\/j.jbc.2022.102860_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1756-3305-3-112","article-title":"Toxoplasmosis of animals and humans","volume":"3","author":"Webster","year":"2010","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.jbc.2022.102860_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pt.2008.01.002","article-title":"A\u00a0hundred-year retrospective on cryptosporidiosis","volume":"24","author":"Tzipori","year":"2008","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.jbc.2022.102860_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/1756-3305-6-365","article-title":"Review of \u201cTrypanosomes and trypanosomiasis\u201d by stefan magez and magdalena radwanska (Editors)","volume":"6","author":"Golding","year":"2013","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.jbc.2022.102860_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40475-021-00232-7","article-title":"A\u00a0review of leishmaniasis: current knowledge and future directions","volume":"8","author":"Mann","year":"2021","journal-title":"Curr. Trop. Med. Rep."},{"key":"10.1016\/j.jbc.2022.102860_bib8","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1007\/s00436-021-07325-2","article-title":"Zoonotic giardiasis: an update","volume":"120","author":"Cai","year":"2021","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.jbc.2022.102860_bib9","series-title":"StatPearls [Internet]","article-title":"Filariasis. [Updated 2022 may 3]","author":"Newman","year":"2022"},{"key":"10.1016\/j.jbc.2022.102860_bib10","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0959-440X(97)80161-3","article-title":"Aminoacyl-tRNA synthetases","volume":"7","author":"Cusack","year":"1997","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jbc.2022.102860_bib11","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1261\/rna.071720.119","article-title":"Aminoacyl-tRNA synthetases","volume":"26","author":"Rubio Gomez","year":"2020","journal-title":"RNA"},{"key":"10.1016\/j.jbc.2022.102860_bib12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-019-0026-3","article-title":"Aminoacyl-tRNA synthetases as therapeutic targets","volume":"18","author":"Kwon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2022.102860_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrm.2017.77","article-title":"The emerging complexity of the tRNA world: mammalian tRNAs beyond protein synthesis","volume":"19","author":"Schimmel","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2022.102860_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104806","article-title":"Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: an up-to-date review","volume":"110","author":"Bouz","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jbc.2022.102860_bib15","doi-asserted-by":"crossref","first-page":"47387","DOI":"10.1074\/jbc.M109089200","article-title":"Structural basis for the recognition of isoleucyl-adenylate and an antibiotic, mupirocin, by isoleucyl-TRNA synthetase","volume":"276","author":"Nakama","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102860_bib16","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1126\/science.1142189","article-title":"An antifungal agent inhibits an aminoacyl-TRNA synthetase by trapping TRNA in the editing site","volume":"316","author":"Rock","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jbc.2022.102860_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpara.2011.11.008","article-title":"Dual targeting of aminoacyl-tRNA synthetases to the apicoplast and cytosol in Plasmodium falciparum","volume":"42","author":"Jackson","year":"2012","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.jbc.2022.102860_bib18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/srep00188","article-title":"Uneven spread of cis- and trans-editing aminoacyl-tRNA synthetase domains within translational compartments of P","volume":"1","author":"Khan","year":"2011","journal-title":"Falciparum. Sci. Rep."},{"key":"10.1016\/j.jbc.2022.102860_bib19","doi-asserted-by":"crossref","first-page":"11669","DOI":"10.1073\/pnas.0502119102","article-title":"Molecular basis of alanine discrimination in editing site","volume":"102","author":"Sokabe","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102860_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007983","article-title":"Targeting tRNA-synthetase interactions towards novel therapeutic discovery against eukaryotic pathogens","volume":"14","author":"Kelly","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jbc.2022.102860_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.chembiol.2012.12.007","article-title":"\"Function-first\" lead discovery: mode of action profiling of natural product libraries using image-based screening","volume":"20","author":"Schulze","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jbc.2022.102860_bib22","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.str.2016.06.018","article-title":"Dimerization of arginyl-tRNA synthetase by free heme drives its inactivation in plasmodium falciparum","volume":"24","author":"Jain","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.jbc.2022.102860_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0166-6851(03)00080-X","article-title":"Expression, localization and alternative function of cytoplasmic asparaginyl-tRNA synthetase in Brugia malayi","volume":"129","author":"Kron","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.jbc.2022.102860_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.molbiopara.2012.06.003","article-title":"Interleukin-8-like activity in a filarial asparaginyl-tRNA synthetase","volume":"185","author":"Kron","year":"2012","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.jbc.2022.102860_bib25","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1086\/501369","article-title":"Brugia malayi asparaginyl-transfer RNA synthetase induces chemotaxis of human leukocytes and activates G-protein-coupled receptors CXCR1 and CXCR2","volume":"193","author":"Ramirez","year":"2006","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.jbc.2022.102860_bib26","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jmb.2010.11.049","article-title":"A\u00a0hybrid structural model of the complete Brugia malayi cytoplasmic asparaginyl-tRNA synthetase","volume":"405","author":"Crepin","year":"2011","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2022.102860_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10822-006-9043-5","article-title":"Discovering new classes of Brugia malayi asparaginyl-tRNA synthetase inhibitors and relating specificity to conformational change","volume":"20","author":"Sukuru","year":"2006","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"key":"10.1016\/j.jbc.2022.102860_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/157016311794519947","article-title":"Asparaginyl-tRNA synthetase pre-transfer editing assay","volume":"8","author":"Danel","year":"2011","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.jbc.2022.102860_bib29","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1021\/ol200420u","article-title":"Tirandamycins from Streptomyces sp. 17944 inhibiting the parasite Brugia malayi asparagine tRNA synthetase","volume":"13","author":"Yu","year":"2011","journal-title":"Org. Lett."},{"key":"10.1016\/j.jbc.2022.102860_bib30","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1021\/ol302298k","article-title":"New WS9326A congeners from Streptomyces sp. 9078 inhibiting Brugia malayi asparaginyl-tRNA synthetase","volume":"14","author":"Yu","year":"2012","journal-title":"Org. Lett."},{"key":"10.1016\/j.jbc.2022.102860_bib31","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/ja.2015.22","article-title":"Adipostatins A-D from Streptomyces sp. 4875 inhibiting Brugia malayi asparaginyl-tRNA synthetase and killing adult Brugia malayi parasites","volume":"68","author":"Rateb","year":"2015","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.jbc.2022.102860_bib32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jmb.2010.01.051","article-title":"Crystal structures of trypanosomal histidyl-tRNA synthetase illuminate differences between eukaryotic and prokaryotic homologs","volume":"397","author":"Merritt","year":"2010","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2022.102860_bib33","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1107\/S1399004715007683","article-title":"A\u00a0binding hotspot in Trypanosoma cruzi histidyl-tRNA synthetase revealed by fragment-based crystallographic cocktail screens","volume":"71","author":"Koh","year":"2015","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2022.102860_bib34","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2174\/156802609790102383","article-title":"Fragment-based cocktail crystallography by the medical structural genomics of pathogenic protozoa consortium","volume":"9","author":"Verlinde","year":"2009","journal-title":"Curr. Top Med. Chem."},{"key":"10.1016\/j.jbc.2022.102860_bib35","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.1011560108","article-title":"Validation of isoleucine utilization targets in Plasmodium falciparum","volume":"108","author":"Istvan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102860_bib36","doi-asserted-by":"crossref","first-page":"14256","DOI":"10.1074\/jbc.M112.447441","article-title":"Inhibition of isoleucyl-tRNA synthetase as a potential treatment for human African Trypanosomiasis","volume":"288","author":"Cestari","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102860_bib37","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1021\/jm101225g","article-title":"Design, synthesis, and structure-activity relationship of Trypanosoma brucei leucyl-tRNA synthetase inhibitors as antitrypanosomal agents","volume":"54","author":"Ding","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2022.102860_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12038-020-00031-8","article-title":"Deciphering the interaction of benzoxaborole inhibitor AN2690 with connective polypeptide 1 (CP1) editing domain of Leishmania donovani leucyl-tRNA synthetase","volume":"45","author":"Tandon","year":"2020","journal-title":"J.\u00a0Biosci."},{"key":"10.1016\/j.jbc.2022.102860_bib39","doi-asserted-by":"crossref","first-page":"e00079-18","DOI":"10.1128\/AAC.00079-18","article-title":"Leishmania donovani parasites are inhibited by the benzoxaborole AN2690 targeting leucyl-tRNA synthetase","volume":"62","author":"Manhas","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jbc.2022.102860_bib40","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bmc.2011.12.035","article-title":"Identification of Trypanosoma brucei leucyl-tRNA synthetase inhibitors by pharmacophore- and docking-based virtual screening and synthesis","volume":"20","author":"Zhao","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jbc.2022.102860_bib41","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1039\/c3ob40236c","article-title":"Discovery of N-(4-sulfamoylphenyl)thioureas as Trypanosoma brucei leucyl-tRNA synthetase inhibitors","volume":"11","author":"Zhang","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jbc.2022.102860_bib42","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.fitote.2012.05.016","article-title":"3,5-Dicaffeoylquinic acid isolated from Artemisia argyi and its ester derivatives exert anti-leucyl-tRNA synthetase of Giardia lamblia (GlLeuRS) and potential anti-giardial effects","volume":"83","author":"Zhang","year":"2012","journal-title":"Fitoterapia"},{"key":"10.1016\/j.jbc.2022.102860_bib43","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1128\/AAC.00820-16","article-title":"Antimalarial benzoxaboroles target plasmodium falciparum leucyl-tRNA synthetase","volume":"60","author":"Sonoiki","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jbc.2022.102860_bib44","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1128\/AAC.00873-16","article-title":"Cryptosporidium and Toxoplasma parasites are inhibited by a benzoxaborole targeting leucyl-tRNA synthetase","volume":"60","author":"Palencia","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jbc.2022.102860_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111827","article-title":"Design and synthesis of \u03b1-phenoxy-N-sulfonylphenyl acetamides as Trypanosoma brucei Leucyl-tRNA synthetase inhibitors","volume":"185","author":"Xin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jbc.2022.102860_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113319","article-title":"Design and synthesis of N-(3-sulfamoylphenyl)amides as Trypanosoma brucei leucyl-tRNA synthetase inhibitors","volume":"217","author":"Li","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jbc.2022.102860_bib47","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.chom.2012.04.015","article-title":"Selective and specific inhibition of the plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin","volume":"11","author":"Hoepfner","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jbc.2022.102860_bib48","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1016\/j.febslet.2014.10.019","article-title":"Crystal structures of Entamoeba histolytica lysyl-tRNA synthetase reveal conformational changes upon lysine binding and a specific helix bundle domain","volume":"588","author":"Bonnefond","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jbc.2022.102860_bib49","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1107\/S0907444913001923","article-title":"Structural analysis of malaria-parasite lysyl-tRNA synthetase provides a platform for drug development","volume":"69","author":"Khan","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2022.102860_bib50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10969-014-9182-1","article-title":"Structural basis of malaria parasite lysyl-tRNA synthetase inhibition by cladosporin","volume":"15","author":"Khan","year":"2014","journal-title":"J.\u00a0Struct. Funct. Genomics"},{"key":"10.1016\/j.jbc.2022.102860_bib51","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/cbic.201200620","article-title":"Selective inhibition of an apicoplastic aminoacyl-tRNA synthetase from Plasmodium falciparum","volume":"14","author":"Hoen","year":"2013","journal-title":"Chembiochem"},{"key":"10.1016\/j.jbc.2022.102860_bib52","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1073\/pnas.1814685116","article-title":"Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis","volume":"116","author":"Baraga\u00f1a","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102860_bib53","doi-asserted-by":"crossref","first-page":"e00340-17","DOI":"10.1128\/mSphereDirect.00340-17","article-title":"Genetic validation of Leishmania donovani lysyl-tRNA synthetase shows that it is indispensable for parasite growth and infectivity","volume":"2","author":"Chadha","year":"2017","journal-title":"mSphere"},{"key":"10.1016\/j.jbc.2022.102860_bib54","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1021\/acsinfecdis.1c00092","article-title":"Design, synthesis, and structural analysis of cladosporin-based inhibitors of malaria parasites","volume":"7","author":"Babbar","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jbc.2022.102860_bib55","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1002\/cbic.202100212","article-title":"Inhibition of plasmodium falciparum lysyl-tRNA synthetase via a piperidine-ring scaffold inspired cladosporin analogues","volume":"22","author":"Babbar","year":"2021","journal-title":"Chembiochem"},{"key":"10.1016\/j.jbc.2022.102860_bib56","doi-asserted-by":"crossref","first-page":"11566","DOI":"10.1093\/nar\/gkaa862","article-title":"Inhibition of Plasmodium falciparum Lysyl-tRNA synthetase via an anaplastic lymphoma kinase inhibitor","volume":"48","author":"Zhou","year":"2020","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.jbc.2022.102860_bib57","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1128\/AAC.01796-10","article-title":"Selective inhibitors of methionyl-tRNA synthetase have potent activity against Trypanosoma brucei Infection in Mice","volume":"55","author":"Shibata","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jbc.2022.102860_bib58","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.biochi.2010.11.015","article-title":"Structure of Leishmania major methionyl-tRNA synthetase in complex with intermediate products methionyladenylate and pyrophosphate","volume":"93","author":"Larson","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.jbc.2022.102860_bib59","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1021\/jm300303e","article-title":"Urea-based inhibitors of trypanosoma brucei methionyl-tRNA synthetase: selectivity and in\u00a0vivo characterization","volume":"55","author":"Shibata","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2022.102860_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002775","article-title":"Structures of Trypanosoma brucei methionyl-tRNA synthetase with urea-based inhibitors provide guidance for drug design against sleeping sickness","volume":"8","author":"Koh","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jbc.2022.102860_bib61","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1039\/D0MD00057D","article-title":"Structure-guided discovery of selective methionyl-tRNA synthetase inhibitors with potent activity against Trypanosoma brucei","volume":"11","author":"Zhang","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.jbc.2022.102860_bib62","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/1087057114548832","article-title":"Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screening","volume":"20","author":"Pedr\u00f3-Rosa","year":"2015","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.jbc.2022.102860_bib63","first-page":"319","article-title":"Ursolic acid, a natural pentacylcic triterpene from Ochrosia elliptica and its role in the management of certain neglected tropical diseases","volume":"12","author":"Labib","year":"2016","journal-title":"Pharmacogn Mag."},{"key":"10.1016\/j.jbc.2022.102860_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2020.131086","article-title":"Design, synthesis, and evaluation of novel anti-trypanosomal compounds","volume":"76","author":"Lepovitz","year":"2020","journal-title":"Tetrahedron"},{"key":"10.1016\/j.jbc.2022.102860_bib65","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/AAC.02220-13","article-title":"Inhibition of protein synthesis and malaria parasite development by drug targeting of methionyl-tRNA synthetases","volume":"59","author":"Hussain","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jbc.2022.102860_bib66","doi-asserted-by":"crossref","first-page":"e02061-18","DOI":"10.1128\/AAC.02061-18","article-title":"Optimization of methionyl tRNA-synthetase inhibitors for treatment of Cryptosporidium infection","volume":"63","author":"Buckner","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jbc.2022.102860_bib67","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.1128\/AAC.01573-15","article-title":"Inhibitors of methionyl-tRNA synthetase have potent activity against Giardia intestinalis trophozoites","volume":"59","author":"Ranade","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jbc.2022.102860_bib68","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/jac\/dkz567","article-title":"Methionyl-tRNA synthetase inhibitor has potent in\u00a0vivo activity in a novel Giardia lamblia luciferase murine infection model","volume":"75","author":"Michaels","year":"2020","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.jbc.2022.102860_bib69","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1021\/acsinfecdis.9b00453","article-title":"Discovery of an allosteric binding site in kinetoplastid methionyl-tRNA synthetase","volume":"6","author":"Torrie","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jbc.2022.102860_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba8412","article-title":"Bicyclic azetidines kill the diarrheal pathogen Cryptosporidium in mice by inhibiting parasite phenylalanyl-tRNA synthetase","volume":"12","author":"Vinayak","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2022.102860_bib71","doi-asserted-by":"crossref","first-page":"e00052-20","DOI":"10.1128\/mBio.00052-20","article-title":"Defining stage-specific activity of potent new inhibitors of Cryptosporidium parvum growth in\u00a0vitro","volume":"11","author":"Funkhouser-Jones","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.jbc.2022.102860_bib72","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41467-022-28108-y","article-title":"Bicyclic azetidines target acute and chronic stages of Toxoplasma gondii by inhibiting parasite phenylalanyl t-RNA synthetase","volume":"13","author":"Radke","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2022.102860_bib73","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/BJ20140998","article-title":"Plasmodium falciparum mitochondria import tRNAs along with an active phenylalanyl-tRNA synthetase","volume":"465","author":"Sharma","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2022.102860_bib74","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.str.2022.03.017","article-title":"Inhibition of Plasmodium falciparum phenylalanine tRNA synthetase provides opportunity for antimalarial drug development","volume":"30","author":"Sharma","year":"2022","journal-title":"Structure"},{"key":"10.1016\/j.jbc.2022.102860_bib75","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41467-020-20478-5","article-title":"Structural basis of malaria parasite phenylalanine tRNA-synthetase inhibition by bicyclic azetidines","volume":"12","author":"Sharma","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2022.102860_bib76","doi-asserted-by":"crossref","first-page":"288ra77","DOI":"10.1126\/scitranslmed.aaa3575","article-title":"The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs","volume":"7","author":"Herman","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2022.102860_bib77","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nchembio.790","article-title":"Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase","volume":"8","author":"Keller","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2022.102860_bib78","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.str.2015.02.011","article-title":"Structure of prolyl-tRNA synthetase-halofuginone complex provides basis for development of drugs against malaria and toxoplasmosis","volume":"23","author":"Jain","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.jbc.2022.102860_bib79","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1107\/S2053230X19014808","article-title":"Conformational heterogeneity in apo and drug-bound structures of Toxoplasma gondii prolyl-tRNA synthetase","volume":"75","author":"Mishra","year":"2019","journal-title":"Acta Crystallogr. F Struct. Biol. Commun."},{"key":"10.1016\/j.jbc.2022.102860_bib80","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10969-014-9186-x","article-title":"Structural and functional analysis of the anti-malarial drug target prolyl-tRNA synthetase","volume":"15","author":"Jain","year":"2014","journal-title":"J.\u00a0Struct. Funct. Genomics"},{"key":"10.1016\/j.jbc.2022.102860_bib81","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.str.2017.07.015","article-title":"Targeting prolyl-tRNA synthetase to accelerate drug discovery against malaria, leishmaniasis, toxoplasmosis, cryptosporidiosis, and coccidiosis","volume":"25","author":"Jain","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.jbc.2022.102860_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010363","article-title":"Double drugging of prolyl-tRNA synthetase provides a new paradigm for anti-infective drug development","volume":"18","author":"Manickam","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jbc.2022.102860_bib83","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1021\/acsinfecdis.1c00020","article-title":"Repositioning and characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors","volume":"7","author":"Okaniwa","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jbc.2022.102860_bib84","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ja.2011.6","article-title":"Borrelidin, a potent antimalarial: stage-specific inhibition profile of synchronized cultures of plasmodium falciparum","volume":"64","author":"Ishiyama","year":"2011","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.jbc.2022.102860_bib85","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/bph.12156","article-title":"Insights into the preclinical treatment of blood-stage malaria by the antibiotic borrelidin","volume":"169","author":"Azc\u00e1rate","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jbc.2022.102860_bib86","doi-asserted-by":"crossref","first-page":"727","DOI":"10.7164\/antibiotics.56.727","article-title":"In\u00a0vitro and in\u00a0vivo antimalarial activities of a non-glycosidic 18-membered macrolide antibiotic, borrelidin, against drug-resistant strains of Plasmodia","volume":"56","author":"Otoguro","year":"2003","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.jbc.2022.102860_bib87","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.bmcl.2013.02.075","article-title":"Borrelidin analogues with antimalarial activity: design, synthesis and biological evaluation against plasmodium falciparum parasites","volume":"23","author":"Sugawara","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2022.102860_bib88","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1128\/EC.00017-14","article-title":"Genetic validation of aminoacyl-tRNA synthetases as drug targets in Trypanosoma brucei","volume":"13","author":"Kalidas","year":"2014","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.jbc.2022.102860_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006575","article-title":"Genetic manipulation of Leishmania donovani threonyl tRNA synthetase facilitates its exploration as a potential therapeutic target","volume":"12","author":"Chadha","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jbc.2022.102860_bib90","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1073\/pnas.0602362103","article-title":"Dual targeting of a single tRNA(Trp) requires two different tryptophanyl-tRNA synthetases in Trypanosoma brucei","volume":"103","author":"Charri\u00e8re","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102860_bib91","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jsb.2010.04.010","article-title":"The structure of tryptophanyl-tRNA synthetase from Giardia lamblia reveals divergence from eukaryotic homologs","volume":"171","author":"Arakaki","year":"2010","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.jbc.2022.102860_bib92","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.molbiopara.2011.01.003","article-title":"Crystal structures of three protozoan homologs of tryptophanyl-tRNA synthetase","volume":"177","author":"Merritt","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.jbc.2022.102860_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066224","article-title":"An appended domain results in an unusual architecture for malaria parasite tryptophanyl-tRNA synthetase","volume":"8","author":"Khan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2022.102860_bib94","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.molbiopara.2013.04.007","article-title":"Crystal structures of Plasmodium falciparum cytosolic tryptophanyl-tRNA synthetase and its potential as a target for structure-guided drug design","volume":"189","author":"Koh","year":"2013","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.jbc.2022.102860_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/srep27531","article-title":"Selective inhibition of apicoplast tryptophanyl-tRNA synthetase causes delayed death in Plasmodium falciparum","volume":"6","author":"Pasaje","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2022.102860_bib96","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jmb.2011.03.026","article-title":"The double-length tyrosyl-tRNA synthetase from the eukaryote Leishmania major forms an intrinsically asymmetric pseudo-dimer","volume":"409","author":"Larson","year":"2011","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2022.102860_bib97","doi-asserted-by":"crossref","first-page":"17754","DOI":"10.1074\/jbc.M116.727107","article-title":"Twin attributes of tyrosyl-tRNA synthetase of Leishmania donovani: a housekeeping protein translation enzyme and a mimic of host chemokine","volume":"291","author":"Anand","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102860_bib98","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biochi.2017.04.006","article-title":"Leishmania donovani tyrosyl-tRNA synthetase structure in complex with a tyrosyl adenylate analog and comparisons with human and protozoan counterparts","volume":"138","author":"Barros-\u00c1lvarez","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.jbc.2022.102860_bib108","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/ncomms1522","article-title":"Malaria parasite tyrosyl-tRNA synthetase secretion triggers pro-inflammatory responses","volume":"2","author":"Bhatt","year":"2011","journal-title":"Nat Commun"},{"key":"10.1016\/j.jbc.2022.102860_bib100","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.abn0611","article-title":"Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy","volume":"376","author":"Xie","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jbc.2022.102860_bib101","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molbiopara.2009.10.005","article-title":"Crystal structure of the aspartyl-tRNA synthetase from Entamoeba histolytica","volume":"169","author":"Merritt","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.jbc.2022.102860_bib102","doi-asserted-by":"crossref","first-page":"16210","DOI":"10.1074\/jbc.M109.005348","article-title":"Dual targeting of a tRNAAsp requires two different aspartyl-tRNA synthetases in Trypanosoma brucei","volume":"284","author":"Charri\u00e8re","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102860_bib103","doi-asserted-by":"crossref","first-page":"18893","DOI":"10.1074\/jbc.M109.015297","article-title":"Plasmodial aspartyl-tRNA synthetases and peculiarities in Plasmodium falciparum","volume":"284","author":"Bour","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102860_bib104","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.exppara.2012.04.013","article-title":"Babesia bovis: a bipartite signal directs the glutamyl-tRNA synthetase to the apicoplast","volume":"131","author":"Pedroni","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.jbc.2022.102860_bib105","doi-asserted-by":"crossref","first-page":"32539","DOI":"10.1074\/jbc.M113.507467","article-title":"A\u00a0nondiscriminating glutamyl-tRNA synthetase in the plasmodium apicoplast: the first enzyme in an indirect aminoacylation pathway","volume":"288","author":"Mailu","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102860_bib107","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/BJ20131451","article-title":"A dual-targeted aminoacyl-tRNA synthetase in Plasmodium falciparum charges cytosolic and apicoplast tRNACys","volume":"458","author":"Pham","year":"2014","journal-title":"Biochem J"},{"key":"10.1016\/j.jbc.2022.102860_bib106","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pt.2016.12.007","article-title":"Repurposing of potent drug candidates for multiparasite targeting","volume":"33","author":"Jain","year":"2017","journal-title":"Trends Parasitol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925822013035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925822013035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:33:59Z","timestamp":1758242039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925822013035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":107,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0021925822013035"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2022.102860","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of aminoacyl-tRNA synthetases from eukaryotic parasites for drug development","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2022.102860","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"102860"}}